Last reviewed · How we verify
NCT04776421
Diverting Ileostomy and Anal Functional Outcomes After Anus Preservation Surgery
trial testing Diverting ileostomy in Diverting Ileostomy in 300 participants. Status unknown.
1 March 2022
Quick facts
| Lead sponsor | The First Hospital of Jilin University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 April 2021 |
| Primary completion | 1 March 2022 |
| Estimated completion | 1 March 2023 |
Drugs / interventions tested
- Diverting ileostomy
Conditions studied
- Diverting Ileostomy — all drugs for Diverting Ileostomy →
- Middle and Low Rectal Cancer — all drugs for Middle and Low Rectal Cancer →
- Functional Outcome — all drugs for Functional Outcome →
- Stoma Complications — all drugs for Stoma Complications →
Sponsor
The First Hospital of Jilin University
Who can join
Adults 18 to 75, any sex, with Diverting Ileostomy or Middle and Low Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Analyze the occurrence of complications, rectal function and quality of life after anus-preserving surgery for middle and low rectal cancer, so as to evaluate the role of protective ileostomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04776421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diverting ileostomy
Trials testing the same drug.
- NCT07283952 — Diverting Ileostomy and Transverse Colostomy Comparative Study · NA · not yet recruiting
- NCT05985252 — Virtual Ileostomy Versus Conventional Loop Ileostomy · NA · unknown
Other The First Hospital of Jilin University trials
Trials by the same sponsor.
- NCT07308340 — Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT · not yet recruiting
- NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
- NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients · not yet recruiting
- NCT07440368 — Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness · not yet recruiting
- NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04776421 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Jilin University
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing